Testing treatment before surgery for babies with infant-type hemispheric glioma
Original title: Molecularly Stratified Trial for Newly Diagnosed Infant-Type Hemispheric Glioma
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
This is a middle stage study, so no one knows yet if it helps.
Status: Not yet recruiting. It has not opened yet. Ask your care team to watch for it if it looks like a fit.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This study tests whether treatment given before surgery makes surgery safer for babies with this brain tumor.
Who this trial is for. This trial is for babies just found to have infant-type hemispheric glioma: A tumor that starts in the glial cells. Those are the support cells of the brain and spinal cord. Gliomas are given a grade from 1 to 4. The grade says how the tumor is expected to act. See the glossary, also called IHG. It tests giving treatment before surgery.
Where it stands. The trial looks at whether surgery is safer and goes better when treatment comes first. That answer is not in yet. The trial has not reported results.
What this means, and what it doesn't
What it could mean: A family whose baby has this tumor could ask their care team about this study. The care team can say if it might fit.
What it doesn't mean: This does not mean the approach works. A trial is a test, not a proven treatment. Being in one is not a guarantee that a child will be helped. It is not a promise of a cure.
Source: ClinicalTrials.gov, November 4, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.